Morgan Stanley’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $20M | Sell |
|
|||||
|
2022
Q2 | $14.9M | Sell |
|
|||||
|
2022
Q1 | $28.6M | Sell |
|
|||||
|
2021
Q4 | $28.3M | Buy |
|
|||||
|
2021
Q3 | $25.3M | Buy |
|
|||||
|
2021
Q2 | $29.9M | Buy |
|
|||||
|
2021
Q1 | $31.2M | Sell |
|
|||||
|
2020
Q4 | $23.6M | Buy |
|
|||||
|
2020
Q3 | $17.4M | Buy |
|
|||||
|
2020
Q2 | $18.2M | Buy |
|
|||||
|
2020
Q1 | $9.79M | Sell |
|
|||||
|
2019
Q4 | $20.1M | Buy |
|
|||||
|
2019
Q3 | $14.7M | Buy |
|
|||||
|
2019
Q2 | $15.5M | Buy |
|
|||||
|
2019
Q1 | $24.2M | Buy |
|
|||||
|
2018
Q4 | $16.1M | Buy |
|
|||||
|
2018
Q3 | $22.5M | Sell |
|
|||||
|
2018
Q2 | $31.6M | Sell |
|
|||||
|
2018
Q1 | $42.7M | Buy |
|
|||||
|
2017
Q4 | $34M | Buy |
|
|||||
|
2017
Q3 | $4.86M | Sell |
|
|||||
|
2017
Q2 | $7.29M | Buy |
|
|||||
|
2017
Q1 | $4.2M | Sell |
|
|||||
|
2016
Q4 | $4.82M | Buy |
|
|||||
|
2016
Q3 | $2.31M | Buy |
|
|||||
|
2016
Q2 | $769K | Buy |
|
|||||
|
2016
Q1 | $294K | Buy |
|
|||||
|
2015
Q4 | $280K | Sell |
|
|||||
|
2015
Q3 | $748K | Sell |
|
|||||
|
2015
Q2 | $1.34M | Buy |
|
|||||
|
2015
Q1 | $2.03M | Buy |
|
|||||
|
2014
Q4 | $490K | Sell |
|
|||||
|
2014
Q3 | $403K | Buy |
|
|||||
|
2014
Q2 | $212K | Buy |
|
|||||
|
2014
Q1 | $105K | Sell |
|
|||||
|
2013
Q4 | $400K | Buy |
|